HRSA HAB is implementing changes to the ADR that will be effective for the 2021 ADR submitted in June 2022. This In Focus document provides a summary of some the major changes as well as tables with all detailed changes.
The purpose of the changes is to:
- Increase the ADR’s alignment with the Ryan White HIV/AIDS Program Services Report (RSR) and compliance with OMB-mandated data reporting requirements
- Reduce burden on recipients by combining or deleting obsolete or unused variables
- Increase data quality by aligning with structured pharmaceutical databases and National Drug Codes (NDCs)
- Improve response options to reflect program practices and support HRSA’s analysis and understanding of program impact